Computed tomography imaging performed with an ultra-fast 320-detector scanner accurately assesses the need for cardiac angioplasty.
Computed tomography imaging performed with an ultra-fast 320-detector scanner accurately assesses the need for cardiac angioplasty, show results of a study presented today at the European Society of Cardiology Congress in Munich, Germany.
Researchers assessed the accuracy of testing used to determine the need for angioplasty among people who are having chest pain but not a heart attack. A total of 381 patients completed the study. They underwent traditional SPECT tests, invasive angiography, and two types of 320-detector CT exams: CTA, in which the scanner was used to visualize the vessel anatomy, and CTP, in which patients were tested with the same machine, but after they had been given a vasodilator.
The 320-detector CT scanner not only showed the anatomy of the blockages, but also whether the blockages were causing a lack of perfusion to the heart.
“We were therefore able to correctly identify the patients who needed revascularization within 30 days of their evaluation,” Carlos E. Rochitte, MD, a cardiologist at the Instituto do Coracao in Sao Paulo, Brazil, and lead author of the study said in a release.
“We found an excellent correlation in results when we compared the 320-detector CT testing with the traditional means of assessment using stress test with imaging and cardiac catheterization,” added Joao A. C. Lima, MD, a professor of medicine and radiology at the Johns Hopkins University School of Medicine and senior author.
The patients will be followed for up to five more years so researchers can track any heart-related events, hospital admissions, procedures and surgeries.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.